Symbols / SKIN
SKIN Chart
About
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.
Fundamentals
Scroll to Statements| Sector | Consumer Defensive | Industry | Household & Personal Pro | Market Cap | 123.93M |
| Enterprise Value | 285.52M | Income | -11.74M | Sales | 301.92M |
| Book/sh | 0.52 | Cash/sh | 1.71 | Dividend Yield | — |
| Payout | 0.00% | Employees | 769 | IPO | — |
| P/E | — | Forward P/E | 6.48 | PEG | — |
| P/S | 0.41 | P/B | 1.88 | P/C | — |
| EV/EBITDA | -182.44 | EV/Sales | 0.95 | Quick Ratio | 3.92 |
| Current Ratio | 4.98 | Debt/Eq | 577.19 | LT Debt/Eq | — |
| EPS (ttm) | -0.18 | EPS next Y | 0.15 | EPS Growth | — |
| Revenue Growth | -10.30% | Earnings | 2026-03-12 | ROA | -2.92% |
| ROE | -18.73% | ROIC | — | Gross Margin | 64.81% |
| Oper. Margin | -8.83% | Profit Margin | -3.89% | Shs Outstand | 127.50M |
| Shs Float | 82.58M | Short Float | 27.68% | Short Ratio | 42.99 |
| Short Interest | — | 52W High | 2.69 | 52W Low | 0.78 |
| Beta | 1.15 | Avg Volume | 581.73K | Volume | 537.57K |
| Target Price | $2.03 | Recom | Hold | Prev Close | $0.89 |
| Price | $0.97 | Change | 9.41% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$2.03
Mean price target
2. Current target
$0.97
Latest analyst target
3. DCF / Fair value
$5.38
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.97
Low
$1.50
High
$3.50
Mean
$2.03
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-21 | main | TD Cowen | Hold → Hold | $2 |
| 2025-09-22 | main | TD Cowen | Hold → Hold | $3 |
| 2025-09-19 | init | Roth Capital | — → Buy | $4 |
| 2025-05-05 | main | Canaccord Genuity | Hold → Hold | $1 |
| 2025-03-13 | main | Canaccord Genuity | Hold → Hold | $2 |
| 2024-11-13 | main | Canaccord Genuity | Hold → Hold | $2 |
| 2024-08-12 | main | Canaccord Genuity | Hold → Hold | $1 |
| 2024-08-09 | reit | Piper Sandler | Underweight → Underweight | $1 |
| 2024-07-26 | main | Stifel | Hold → Hold | $2 |
| 2024-07-11 | main | Piper Sandler | Underweight → Underweight | $2 |
| 2024-05-13 | main | DA Davidson | Buy → Buy | $5 |
| 2024-05-13 | main | TD Cowen | Hold → Hold | $3 |
| 2024-05-10 | main | Piper Sandler | Underweight → Underweight | $3 |
| 2024-03-15 | main | DA Davidson | Buy → Buy | $5 |
| 2024-03-14 | main | Canaccord Genuity | Hold → Hold | $4 |
| 2024-03-13 | reit | Stifel | Hold → Hold | $4 |
| 2024-03-13 | main | TD Cowen | Market Perform → Market Perform | $4 |
| 2024-03-13 | reit | Piper Sandler | Underweight → Underweight | $3 |
| 2024-02-29 | main | Canaccord Genuity | Hold → Hold | $3 |
| 2023-11-15 | down | Jefferies | Buy → Hold | $2 |
- Why This Top 2% Biotech Just Blew Past Its 50-Day Line - Investor's Business Daily ue, 24 Feb 2026 21
- Why BeautyHealth (SKIN) Stock Is Nosediving - Yahoo Finance ue, 23 Sep 2025 07
- STRATA Skin Sciences stock plunges after Nasdaq delisting notice - Investing.com hu, 12 Feb 2026 08
- Nu Skin Still Has Long-Term Turnaround Potential (NYSE:NUS) - Seeking Alpha hu, 19 Feb 2026 13
- Dermatology device maker STRATA Skin exits Nasdaq to cut costs - Stock Titan hu, 19 Feb 2026 21
- Why Is Nu Skin Stock Sinking Friday? - Nu Skin Enterprises (NYSE:NUS) - Benzinga Fri, 13 Feb 2026 08
- NKTR Stock Skyrockets: Wall Street Sees Up To 200% Upside As Skin Trial Crushes Even Bull-Case Forecasts - Stocktwits Wed, 11 Feb 2026 05
- e.l.f. Beauty Announces Definitive Agreement to Acquire rhode in $1 Billion Deal - e.l.f. Beauty Wed, 28 May 2025 07
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Surges 36% Yet Its Low P/S Is No Reason For Excitement - simplywall.st Sat, 18 Oct 2025 07
- Nu Skin Enterprises (NYSE:NUS) shareholders have endured a 77% loss from investing in the stock five years ago - Yahoo Finance ue, 14 Oct 2025 07
- Earnings call transcript: Nu Skin misses Q4 2025 earnings forecast, stock rises - Investing.com hu, 12 Feb 2026 08
- BeautyHealth (NASDAQ: SKIN) schedules Q3 2025 results; webcast and investor call - Stock Titan hu, 23 Oct 2025 07
- Nu Skin: Valuation Is Low, But Challenges Remain (NYSE:NUS) - Seeking Alpha hu, 18 Dec 2025 08
- BeautyHealth (NASDAQ:SKIN) Beats Q3 Sales Expectations, Stock Jumps 16.7% - Yahoo Finance hu, 06 Nov 2025 08
- Nu Skin to Report Q3 Earnings: What's in the Cards for NUS Stock? - Yahoo Finance Wed, 05 Nov 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 57692 | — | — | Stock Award(Grant) at price 0.00 per share. | SCHAISON PHILIPPE | Director | — | 2025-11-13 00:00:00 | D |
| 1 | 2190384 | 3416999 | — | Stock Award(Grant) at price 1.56 per share. | MALHA PEDRO BRUNO FERREIRA | Chief Executive Officer | — | 2025-10-09 00:00:00 | D |
| 2 | 73051 | — | — | Stock Award(Grant) at price 0.00 per share. | FANNING STEPHEN J | Director | — | 2025-06-16 00:00:00 | D |
| 3 | 73051 | — | — | Stock Award(Grant) at price 0.00 per share. | SAUNDERS BRENT L. | Chairman of the Board | — | 2025-06-16 00:00:00 | D |
| 4 | 73051 | — | — | Stock Award(Grant) at price 0.00 per share. | KERRICK MICHELLE C. | Director | — | 2025-06-16 00:00:00 | D |
| 5 | 73051 | — | — | Stock Award(Grant) at price 0.00 per share. | GRUBER DESIREE | Director | — | 2025-06-16 00:00:00 | D |
| 6 | 73051 | — | — | Stock Award(Grant) at price 0.00 per share. | SCHILLINGER DOUG K. | Director | — | 2025-06-16 00:00:00 | D |
| 7 | 73051 | — | — | Stock Award(Grant) at price 0.00 per share. | MILLER BRIAN CHRISTOPHER | Director | — | 2025-06-16 00:00:00 | D |
| 8 | 639204 | 843749 | — | Stock Award(Grant) at price 1.32 per share. | MONAHAN MICHAEL P | Chief Financial Officer | — | 2025-03-17 00:00:00 | D |
| 9 | 1832386 | 2418750 | — | Stock Award(Grant) at price 1.32 per share. | BECK MARLA MALCOLM | Chief Executive Officer | — | 2025-03-17 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -23.57K | 243.17K | 1.85M | -1.62M |
| TaxRateForCalcs | 0.01 | 0.02 | 0.02 | 0.01 |
| NormalizedEBITDA | 16.11M | -67.87M | 4.56M | -26.45M |
| TotalUnusualItems | -1.57M | 14.30M | 77.05M | -324.48M |
| TotalUnusualItemsExcludingGoodwill | -1.57M | 14.30M | 77.05M | -324.48M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -29.10M | -100.12M | 44.22M | -378.76M |
| ReconciledDepreciation | 33.68M | 34.67M | 22.87M | 17.93M |
| ReconciledCostOfRevenue | 152.00M | 242.88M | 117.10M | 81.55M |
| EBITDA | 14.54M | -53.56M | 81.60M | -350.93M |
| EBIT | -19.14M | -88.24M | 58.73M | -368.86M |
| NetInterestIncome | 6.23M | 9.52M | -4.22M | -11.74M |
| InterestExpense | 10.41M | 13.65M | 13.39M | 11.78M |
| InterestIncome | 16.64M | 23.17M | 9.18M | 39.00K |
| NormalizedIncome | -27.55M | -114.18M | -30.97M | -55.90M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -29.10M | -100.12M | 44.22M | -378.76M |
| TotalExpenses | 402.07M | 528.91M | 391.72M | 300.01M |
| TotalOperatingIncomeAsReported | -67.77M | -130.92M | -25.84M | -39.93M |
| DilutedAverageShares | 123.83M | 131.68M | 148.51M | 102.11M |
| BasicAverageShares | 123.83M | 131.68M | 147.55M | 102.11M |
| DilutedEPS | -0.23 | -0.76 | 0.23 | -3.67 |
| BasicEPS | -0.23 | -0.76 | 0.30 | -3.67 |
| DilutedNIAvailtoComStockholders | -51.77M | -100.12M | -34.12M | -378.76M |
| AverageDilutionEarnings | -22.67M | 0.00 | -78.34M | 0.00 |
| NetIncomeCommonStockholders | -29.10M | -100.12M | 44.22M | -378.76M |
| NetIncome | -29.10M | -100.12M | 44.22M | -378.76M |
| NetIncomeIncludingNoncontrollingInterests | -29.10M | -100.12M | 44.22M | -378.76M |
| NetIncomeContinuousOperations | -29.10M | -100.12M | 44.22M | -378.76M |
| TaxProvision | -452.00K | -1.77M | 1.11M | -1.88M |
| PretaxIncome | -29.55M | -101.89M | 45.34M | -380.64M |
| OtherIncomeExpense | 31.99M | 19.50M | 75.40M | -328.97M |
| OtherNonOperatingIncomeExpenses | 33.56M | 5.20M | -1.65M | -4.49M |
| GainOnSaleOfSecurity | -1.57M | 14.30M | 77.05M | -324.48M |
| NetNonOperatingInterestIncomeExpense | 6.23M | 9.52M | -4.22M | -11.74M |
| InterestExpenseNonOperating | 10.41M | 13.65M | 13.39M | 11.78M |
| InterestIncomeNonOperating | 16.64M | 23.17M | 9.18M | 39.00K |
| OperatingIncome | -67.77M | -130.92M | -25.84M | -39.93M |
| OperatingExpense | 250.07M | 286.03M | 274.62M | 218.47M |
| ResearchAndDevelopment | 6.30M | 10.10M | 8.44M | 8.20M |
| SellingGeneralAndAdministration | 243.77M | 275.93M | 266.18M | 210.27M |
| SellingAndMarketingExpense | 118.31M | 144.50M | 160.08M | 111.58M |
| GeneralAndAdministrativeExpense | 125.46M | 131.43M | 106.10M | 98.69M |
| OtherGandA | 125.46M | 131.43M | 106.10M | 98.69M |
| GrossProfit | 182.30M | 155.11M | 248.78M | 178.54M |
| CostOfRevenue | 152.00M | 242.88M | 117.10M | 81.55M |
| TotalRevenue | 334.29M | 397.99M | 365.88M | 260.09M |
| OperatingRevenue | 334.29M | 397.99M | 365.88M | 260.09M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 124.92M | 122.90M | 132.21M | 150.60M |
| ShareIssued | 124.92M | 122.90M | 132.21M | 150.60M |
| NetDebt | 182.13M | 215.35M | 165.95M | |
| TotalDebt | 568.16M | 752.29M | 751.79M | 746.41M |
| TangibleBookValue | -119.21M | -128.55M | -3.93M | 122.59M |
| InvestedCapital | 604.00M | 797.76M | 901.20M | 1.03B |
| WorkingCapital | 408.97M | 583.24M | 711.56M | 924.46M |
| NetTangibleAssets | -119.21M | -128.55M | -3.93M | 122.59M |
| CapitalLeaseObligations | 15.96M | 13.92M | 17.65M | 16.49M |
| CommonStockEquity | 51.80M | 59.39M | 167.05M | 302.30M |
| TotalCapitalization | 604.00M | 797.76M | 901.20M | 1.03B |
| TotalEquityGrossMinorityInterest | 51.80M | 59.39M | 167.05M | 302.30M |
| StockholdersEquity | 51.80M | 59.39M | 167.05M | 302.30M |
| GainsLossesNotAffectingRetainedEarnings | -6.95M | -3.04M | -4.53M | -1.26M |
| OtherEquityAdjustments | -6.95M | -3.04M | -4.53M | -1.26M |
| RetainedEarnings | -507.96M | -478.87M | -378.75M | -418.71M |
| AdditionalPaidInCapital | 566.71M | 541.28M | 550.32M | 722.25M |
| CapitalStock | 12.00K | 12.00K | 14.00K | 16.00K |
| CommonStock | 12.00K | 12.00K | 14.00K | 16.00K |
| PreferredStock | 0.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 633.88M | 869.72M | 836.03M | 916.51M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 565.73M | 754.72M | 764.32M | 840.07M |
| OtherNonCurrentLiabilities | 1.83M | 2.77M | 15.47M | 93.82M |
| DerivativeProductLiabilities | 488.00K | 3.56M | 15.47M | 93.82M |
| NonCurrentDeferredLiabilities | 396.00K | 702.00K | 2.01M | 3.56M |
| NonCurrentDeferredTaxesLiabilities | 396.00K | 702.00K | 2.01M | 3.56M |
| LongTermDebtAndCapitalLeaseObligation | 563.01M | 747.69M | 746.83M | 742.70M |
| LongTermCapitalLeaseObligation | 10.81M | 9.32M | 12.69M | 12.78M |
| LongTermDebt | 552.20M | 738.37M | 734.14M | 729.91M |
| CurrentLiabilities | 68.15M | 115.01M | 71.71M | 76.44M |
| CurrentDeferredLiabilities | 2.38M | 450.00K | ||
| CurrentDeferredRevenue | 2.38M | 450.00K | ||
| CurrentDebtAndCapitalLeaseObligation | 5.15M | 4.60M | 4.96M | 3.71M |
| CurrentCapitalLeaseObligation | 5.15M | 4.60M | 4.96M | 3.71M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.14M | 4.00M | 5.64M | 18.28M |
| CurrentProvisions | 21.01M | |||
| PayablesAndAccruedExpenses | 58.49M | 84.95M | 61.11M | 54.44M |
| CurrentAccruedExpenses | 17.17M | 21.99M | 18.98M | 16.21M |
| InterestPayable | 1.74M | 2.34M | 2.34M | 2.79M |
| Payables | 41.32M | 62.96M | 42.13M | 38.23M |
| OtherPayable | 1.82M | 2.15M | ||
| TotalTaxPayable | 19.38M | 18.19M | 11.84M | 7.03M |
| IncomeTaxPayable | 3.43M | 2.76M | 1.43M | 292.00K |
| AccountsPayable | 21.94M | 44.77M | 28.47M | 29.05M |
| TotalAssets | 685.68M | 929.11M | 1.00B | 1.22B |
| TotalNonCurrentAssets | 208.56M | 230.86M | 219.81M | 217.91M |
| OtherNonCurrentAssets | 14.09M | 16.04M | 14.19M | 6.71M |
| NonCurrentDeferredAssets | 3.89M | 531.00K | 815.00K | 330.00K |
| NonCurrentDeferredTaxesAssets | 3.89M | 531.00K | 815.00K | 330.00K |
| GoodwillAndOtherIntangibleAssets | 171.01M | 187.94M | 170.98M | 179.70M |
| OtherIntangibleAssets | 47.51M | 62.12M | 46.39M | 56.01M |
| Goodwill | 123.50M | 125.82M | 124.59M | 123.69M |
| NetPPE | 19.57M | 26.35M | 33.82M | 31.18M |
| AccumulatedDepreciation | -25.50M | -19.95M | -12.49M | -8.56M |
| GrossPPE | 45.07M | 46.30M | 46.31M | 39.74M |
| Leases | 12.02M | 12.32M | 11.81M | 5.09M |
| ConstructionInProgress | 0.00 | 748.00K | 1.38M | 5.35M |
| OtherProperties | 14.32M | 13.01M | 16.27M | 16.38M |
| MachineryFurnitureEquipment | 18.73M | 20.22M | 16.85M | 12.92M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 477.12M | 698.25M | 783.27M | 1.00B |
| OtherCurrentAssets | 9.49M | 28.88M | 27.65M | 12.32M |
| PrepaidAssets | 12.32M | |||
| Inventory | 69.11M | 91.32M | 109.66M | 35.26M |
| FinishedGoods | 43.09M | 66.92M | 71.28M | 23.24M |
| RawMaterials | 26.02M | 24.41M | 38.37M | 12.02M |
| Receivables | 28.46M | 55.03M | 77.77M | 51.42M |
| TaxesReceivable | 818.00K | 332.00K | 1.28M | 4.60M |
| AccountsReceivable | 27.64M | 54.70M | 76.49M | 46.82M |
| AllowanceForDoubtfulAccountsReceivable | -9.60M | -6.60M | -2.93M | -2.68M |
| GrossAccountsReceivable | 37.24M | 61.30M | 79.42M | 49.51M |
| CashCashEquivalentsAndShortTermInvestments | 370.06M | 523.02M | 568.20M | 901.89M |
| CashAndCashEquivalents | 370.06M | 523.02M | 568.20M | 901.89M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 9.34M | 8.70M | -123.99M | -43.98M |
| RepurchaseOfCapitalStock | 0.00 | -32.40M | -160.00M | 0.00 |
| RepaymentOfDebt | -156.08M | 0.00 | 0.00 | -230.49M |
| IssuanceOfDebt | 0.00 | 0.00 | 755.00M | |
| CapitalExpenditure | -6.79M | -13.05M | -17.39M | -15.62M |
| InterestPaidSupplementalData | 8.01M | 9.38M | 9.82M | 10.25M |
| IncomeTaxPaidSupplementalData | 2.80M | 2.27M | 1.70M | |
| EndCashPosition | 370.06M | 523.02M | 568.20M | 901.89M |
| BeginningCashPosition | 523.02M | 568.20M | 901.89M | 9.49M |
| EffectOfExchangeRateChanges | -3.96M | 2.03M | -2.98M | -543.00K |
| ChangesInCash | -149.00M | -47.20M | -330.71M | 892.94M |
| FinancingCashFlow | -158.34M | -37.45M | -205.24M | 959.03M |
| CashFlowFromContinuingFinancingActivities | -158.34M | -37.45M | -205.24M | 959.03M |
| NetOtherFinancingCharges | -2.26M | -5.05M | -45.24M | 246.14M |
| ProceedsFromStockOptionExercised | 0.00 | 0.00 | 188.38M | |
| NetCommonStockIssuance | 0.00 | -32.40M | -160.00M | 0.00 |
| CommonStockPayments | 0.00 | -32.40M | -160.00M | 0.00 |
| NetIssuancePaymentsOfDebt | -156.08M | 0.00 | 0.00 | 524.51M |
| NetShortTermDebtIssuance | 0.00 | 0.00 | 0.00 | |
| ShortTermDebtPayments | 0.00 | 0.00 | -5.00M | |
| ShortTermDebtIssuance | 0.00 | 0.00 | 5.00M | |
| NetLongTermDebtIssuance | -156.08M | 0.00 | 0.00 | 524.51M |
| LongTermDebtPayments | -156.08M | 0.00 | 0.00 | -225.49M |
| LongTermDebtIssuance | 0.00 | 0.00 | 750.00M | |
| InvestingCashFlow | -6.79M | -31.51M | -18.87M | -37.73M |
| CashFlowFromContinuingInvestingActivities | -6.79M | -31.51M | -18.87M | -37.73M |
| NetOtherInvestingChanges | -18.46M | -1.48M | 781.00K | |
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | -22.90M | |
| PurchaseOfBusiness | 0.00 | 0.00 | -22.90M | |
| NetIntangiblesPurchaseAndSale | -6.04M | -9.22M | -6.55M | -4.42M |
| PurchaseOfIntangibles | -6.04M | -9.22M | -6.55M | -4.42M |
| NetPPEPurchaseAndSale | -756.00K | -3.83M | -10.85M | -11.20M |
| PurchaseOfPPE | -756.00K | -3.83M | -10.85M | -11.20M |
| CapitalExpenditureReported | -17.39M | -15.62M | ||
| OperatingCashFlow | 16.13M | 21.75M | -106.60M | -28.36M |
| CashFlowFromContinuingOperatingActivities | 16.13M | 21.75M | -106.60M | -28.36M |
| ChangeInWorkingCapital | -27.39M | 23.36M | -145.27M | -16.14M |
| ChangeInOtherWorkingCapital | -9.40M | -7.60M | -12.08M | -7.52M |
| ChangeInOtherCurrentLiabilities | -4.03M | -1.39M | ||
| ChangeInOtherCurrentAssets | -8.04M | -6.13M | ||
| ChangeInPayablesAndAccruedExpense | -43.78M | 44.00M | -2.95M | 34.71M |
| ChangeInAccruedExpense | 26.94M | -3.36M | 24.78M | |
| ChangeInPayable | 17.07M | 1.80M | 9.93M | |
| ChangeInAccountPayable | 15.78M | 1.61M | 10.52M | |
| ChangeInTaxPayable | 1.28M | 198.00K | -594.00K | |
| ChangeInIncomeTaxPayable | 1.28M | 198.00K | -594.00K | |
| ChangeInPrepaidAssets | 15.48M | -6.95M | -13.85M | -5.07M |
| ChangeInInventory | -10.50M | -22.62M | -84.36M | -7.29M |
| ChangeInReceivables | 20.80M | 16.52M | -32.02M | -30.98M |
| ChangesInAccountReceivables | 20.80M | 16.52M | -32.02M | -31.01M |
| OtherNonCashItems | -14.11M | 11.30M | 16.44M | 56.89M |
| StockBasedCompensation | 26.70M | 22.54M | 28.50M | 12.42M |
| ProvisionandWriteOffofAssets | 5.13M | 5.15M | 1.62M | 854.00K |
| AssetImpairmentCharge | 28.04M | 37.84M | 5.14M | 1.13M |
| DeferredTax | -3.75M | -1.08M | -1.79M | -3.76M |
| DeferredIncomeTax | -3.75M | -1.08M | -1.79M | -3.76M |
| DepreciationAmortizationDepletion | 33.68M | 34.67M | 22.87M | 17.93M |
| DepreciationAndAmortization | 33.68M | 34.67M | 22.87M | 17.93M |
| AmortizationCashFlow | 23.74M | 23.34M | 15.71M | 13.44M |
| AmortizationOfIntangibles | 23.74M | 23.34M | 15.71M | 13.44M |
| Depreciation | 9.94M | 11.33M | 7.16M | 4.49M |
| OperatingGainsLosses | -3.07M | -11.92M | -78.34M | 277.31M |
| GainLossOnInvestmentSecurities | -3.07M | -11.92M | -78.34M | 277.31M |
| NetForeignCurrencyExchangeGainLoss | 2.41M | 0.00 | ||
| GainLossOnSaleOfPPE | 5.24M | 0.00 | ||
| NetIncomeFromContinuingOperations | -29.10M | -100.12M | 44.22M | -378.76M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for SKIN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|